Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PlexusDx's $298 genetic test analyzes 150+ insights across 49 peptides, including GIPR variants that directly influence how your body responds to tirzepatide versus semaglutide
GLP-1 therapies address one of them particularly well
Additionally, GLP-1 RAs with established CV benefitsspecifically liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatideare recommended for patients with T2DM and ASCVD to reduce CV events, regardless of baseline or target HbA1c levels or concurrent glucose-lowering therapy (Class I, LoE A)
One of the biggest mistakes patients make is believing that a higher dose automatically means better results
Key Takeaways 2026 is different: GLP-1 medications are transforming weight loss, but success requires professional nutritional support to manage side effects and maintain results
Retatrutide Retatrutide represents the most advanced triple agonist aiming GLP-1, GIP, and GCG simultaneously
US$ 27.59
US$ 28.33
US$ 29.62
